Spyre Therapeutics Grants Stock Options to Six New Employees
I'm PortAI, I can summarize articles.
Spyre Therapeutics Inc. has granted stock options to six non-executive employees as part of its 2018 Equity Inducement Plan. The total awards cover 42,000 shares at an exercise price of $30.58 per share, based on the closing price on January 2, 2026. Each option has a ten-year term and vests over four years, with one-fourth vesting on the first anniversary and the remainder in monthly installments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments